Skip to main content
Halozyme Therapeutics, Inc. (HALO)
NASDAQ: HALO · Real-Time Price · USD
54.80
-0.57 (-1.03%)
At close: Jan 17, 2025, 4:00 PM
55.07
+0.27 (0.49%)
Pre-market: Jan 21, 2025, 9:03 AM EST

Halozyme Therapeutics Revenue by Segment
Period Ending Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018
Royalties
522.62M 482.00M 468.82M 447.87M 431.79M 416.91M 390.51M 360.48M
Royalties Growth
21.04% 15.61% 20.05% 24.24% 36.16% 50.98% 65.06% 76.79%
Product Sales
303.73M 303.64M 298.64M 300.85M 282.42M 257.27M 229.68M 191.03M
Product Sales Growth
7.55% 18.02% 30.02% 57.49% 79.98% 113.44% 119.59% 83.29%
Revenues Under Collaborative Agreements
121.00M 87.67M 95.53M 80.53M 66.50M 99.47M 84.79M 108.61M
Revenues Under Collaborative Agreements Growth
81.95% -11.86% 12.67% -25.85% -37.60% 9.55% -34.97% -19.66%

Operating Expense Breakdown
Period Ending Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018
Cost of Sales
169.66M 175.06M 185.52M 192.36M 182.18M 174.68M 158.55M 139.30M
Cost of Sales Growth
-6.87% 0.22% 17.01% 38.09% 53.39% 94.00% 100.40% 71.11%
Selling, General, and Administrative
149.69M 143.72M 146.96M 149.18M 149.32M 148.52M 167.05M 143.53M
Selling, General, and Administrative Growth
0.25% -3.23% -12.03% 3.94% 24.90% 51.16% 214.61% 185.21%
Research and Development
79.94M 78.81M 77.50M 76.36M 77.59M 76.98M 72.73M 66.61M
Research and Development Growth
3.03% 2.38% 6.55% 14.65% 43.30% 67.60% 88.84% 86.72%
Amortization
71.05M 73.63M 73.70M 73.77M 60.56M 67.42M 60.98M 43.15M
Amortization Growth
17.31% 9.22% 20.85% 70.98% 56.92% 491.20% - -
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.